Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma-Reference-Cited by-同舟云学术

Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma

Published:2019-06 Issue:6 Volume:27 Page:1126-1138
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Sommer Cesar,Boldajipour Bijan,Kuo Tracy C.,Bentley Trevor,Sutton Janette,Chen Amy,Geng Tao,Dong Holly,Galetto Roman,Valton Julien,Pertel Thomas,Juillerat Alexandre,Gariboldi Annabelle,Pascua Edward,Brown Colleen,Chin Sherman M.,Sai Tao,Ni Yajin,Duchateau Philippe,Smith Julianne,Rajpal Arvind,Van Blarcom Thomas,Chaparro-Riggers Javier,Sasu Barbra J.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference61 articles.

1. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N. Engl. J. Med.,2017

2. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N. Engl. J. Med.,2018

3. When aging reaches CD4+ T-cells: phenotypic and functional changes;Moro-García;Front. Immunol.,2013

4. Thymic involution and rising disease incidence with age;Palmer;Proc. Natl. Acad. Sci. USA,2018

5. T cell ageing: effects of age on development, survival & function;Salam;Indian J. Med. Res.,2013

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies;Blood Reviews;2024-09

2. Effects of Consolidation Therapy With Autologous Hematopoietic Stem Cell Transplantation After BCMA-CAR T-Cell Therapy on the Survival of Patients With Relapsed or Refractory Multiple Myeloma;Transplantation and Cellular Therapy;2024-09

3. Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma;Journal for ImmunoTherapy of Cancer;2024-07

4. Imaging‐Based Efficacy Evaluation of Cancer Immunotherapy in Engineered Tumor Platforms and Tumor Organoids;Advanced Healthcare Materials;2024-06-08

5. BCMA/CD47-directed universal CAR-T cells exhibit excellent antitumor activity in multiple myeloma;Journal of Nanobiotechnology;2024-05-23